US EditionSimple tweak to cervical cancer treatment cuts risk of death by 40%, say researchers
- A new treatment protocol has been shown to cut the risk of death from cervical cancer by 40 percent, according to a large-scale study.
- The Interlace phase III trial found that a short course of induction chemotherapy prior to chemoradiation reduced the risk of cancer returning by 35 percent.
- Dr. Mary McCormack stated this treatment could positively impact patients using existing, inexpensive drugs and called for its wider rollout.
52 Articles
52 Articles
New cervical cancer treatment delivers results
A new cervical cancer treatment that has been trialled over the past ten years has been shown to reduce the risk of dying by 40%. This has been the biggest advance in fighting the disease in 25 years. Cervical cancer is the fourth most common cancer in women and over 300,000 females develop the disease globally. The trial patients recruited lived in Italy, Brazil, the US, India, and Mexico. Source
New cervical cancer treatment cuts risk of death from disease, according to trial results - WSVN 7News | Miami News, Weather, Sports
(CNN) — Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows. The study, published Monday in the journal The Lancet, involved 500 patients from 32 medical centers in Brazil, India, Italy, Mexico and the UK who were randomly assigned into two groups between 2012 and 2022. All had locally advanced cervical cancer, al…
New cervical cancer treatment cuts risk of death from disease, according to trial results – KION546
By Sam Tupper (CNN) — Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows. The study, published Monday in the journal The Lancet, involved 500 patients from 32 medical centers in Brazil, India, Italy, Mexico and the UK who were randomly assigned into two groups between 2012 and 2022. All had locally advanced cervi…
New Cervical Cancer Regime Cuts Death Rate by 40 Percent, Study Shows
A large-scale study has shown that a new treatment protocol cuts the risk of death from cervical cancer by 40 percent. Researchers at University College London (UCL) and University College London Hospital (UCLH) have completed a long-term follow-up of patients given a short course of chemotherapy before chemoradiation (a combination of chemotherapy and radiotherapy). The trial began in November 2012 and ended in November 2022. The findings, whic…
This new treatment plan, which starts with six weeks of chemotherapy, also reduces the risk of recurrence by 35%, according to the results of a trial by a team from University College London, published in “The Lancet” on October 14.
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
